Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulphasalazine.
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D001344:Autopsy; D001855:Bone Marrow Diseases / Q000139:chemically induced*; D003093:Colitis, Ulcerative / Q000188:drug therapy; D006801:Humans; D008297:Male; D013262:Stevens-Johnson Syndrome / Q000209:etiology*; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use
D012460:Sulfasalazine